Princeton, New Jersey, United States, June 2024 – Sujeet Singh has joined Padagis LLC as the Chief Growth Officer. With a strong background in strategic portfolio management and business development, Sujeet is set to drive growth and innovation at Padagis LLC, aiming to expand the company’s leadership in the healthcare sector.
Sujeet Singh brings a wealth of experience to Padagis LLC, having held significant leadership positions in the pharmaceutical industry. At Padagis, he will focus on strategic growth initiatives and expanding the company’s portfolio of healthcare products.
Prior to joining Padagis LLC, Sujeet served as the Chief Portfolio Management Officer at Azurity Pharmaceuticals. During his tenure, he created the strategic roadmap for pipeline building and oversaw the introduction of new ideas across therapeutic areas, dosage forms, and lifecycle management processes.
Sujeet co-founded Calyptus Pharmaceuticals, Inc., where he served as the CEO and Board Member. He led the company in delivering a portfolio of sterile products to hospitals, community clinics, and retail pharmacies. Under his leadership, Calyptus Pharmaceuticals developed and launched several complex injectable products.
Before Calyptus Pharmaceuticals, Sujeet spent over 14 years at Dr. Reddy’s Laboratories. He held various roles, including Vice President & Head of Strategic Portfolio & Business Development for North America Generics. He was instrumental in building a sustainable and growing complex generics business, collaborating with research and manufacturing partners, and mentoring R&D teams.
Sujeet also held positions at Siemens India, Ltd. and Infosys early in his career, where he gained valuable experience in corporate finance and software engineering.
Padagis LLC is dedicated to improving the well-being of patients and consumers by providing high-quality, affordable, specialized healthcare products. The company is a leading provider of extended topical and other specialty pharmaceuticals. With a focus on healthcare products that improve people’s lives, Padagis strategically invests in expanding its #1 position in the extended topical category in the United States. The company’s team members, numbering more than 1,300, work in a dynamic environment built on a foundation of honesty and transparency.
Read Also : Imagination in a Disrupted Age: Navigating the Future with Curiosity and Empathy
